Cronos (CRON) Non Operating Investment Income (2019 - 2024)
Cronos (CRON) posted quarterly Non Operating Investment Income of $32.5 million for Q3 2024, up 70484.78% quarter-over-quarter from $46000.0 in Q4 2020.
Cronos (CRON) Non Operating Investment Income (2019 - 2024) Analysis & Trends
Cronos' Non Operating Investment Income history runs 3 years deep, the most recent figure standing at $32.5 million for Q3 2024.
- In Q3 2024, Non Operating Investment Income changed N/A year-over-year to $32.5 million; the TTM figure through Dec 2025 stood at $32.5 million (changed 0.0% YoY), while the FY2024 annual figure was $32.5 million, changed N/A from the prior year.
- Non Operating Investment Income for Q3 2024 stood at $32.5 million, up from $46000.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $32.5 million in Q3 2024, with the low at $46000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 32.47 Mn |
| Sep 30, 2024 | 32.47 Mn |
| Dec 31, 2020 | 46,000.00 |
| Dec 31, 2020 | 46,000.00 |
| Sep 30, 2020 | 3.97 Mn |
| Sep 30, 2020 | 3.97 Mn |
| Dec 31, 2019 | 35,000.00 |
| Dec 31, 2019 | 35,000.00 |